USE OF WARFARIN THERAPY AND RISK STRATIFICATION TOOLS FOR ATRIAL FIBRILLATION PATIENTS

被引：0
|
作者：
Winfield, Julia [1 ]
Barnes, Geoffrey D. [1 ]
Kaatz, Scott [1 ]
Gu, Xiaokui [1 ]
Kline-Rogers, Eva [1 ]
Kozlowski, Jay [1 ]
Hickman, Leaden [1 ]
Leyden, Thomas [1 ]
Besley, Dennis [1 ]
Haymart, Brian [1 ]
Leidal, Adam [1 ]
Theurer, Allison [1 ]
Froehlich, James B. [1 ]
机构：
[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 14期
关键词：
D O I：
10.1016/S0735-1097(11)61245-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1245 / E1245
页数：1
相关论文
共 50 条
  • [31] New biomarkers in risk stratification in patients with atrial fibrillation
    Makowski, Marcin
    Baj, Zbigniew
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 247 : 19 - 19
  • [32] Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
    Hijazi, Ziad
    Oldgren, Jonas
    Siegbahn, Agneta
    Wallentin, Lars
    CLINICAL CHEMISTRY, 2017, 63 (01) : 152 - 164
  • [33] Stroke in atrial fibrillation: Review of risk stratification and preventive therapy
    Alshehri, Abdullah M.
    JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2019, 26 (02): : 92 - 97
  • [34] Warfarin therapy for atrial fibrillation in the elderly
    Lackie, CL
    Garbarino, KA
    Pruetz, JA
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) : 200 - 204
  • [35] NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin
    Wallentin, L. C.
    Christersson, C.
    Siegbahn, A.
    Schollin, M.
    Alexander, J. H.
    Hanna, M.
    Hylek, E. M.
    Horowitz, J.
    McMurray, J. J. V.
    Granger, C. B.
    EUROPEAN HEART JOURNAL, 2012, 33 : 51 - 51
  • [36] The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients
    Angaran, Paul
    Dorian, Paul
    Tan, Mary K.
    Kerr, Charles R.
    Green, Martin S.
    Gladstone, David J.
    Mitchell, L. Brent
    Fournier, Carl
    Cox, Jafna L.
    Talajic, Mario
    Lin, Peter J.
    Langer, Anatoly
    Goldin, Lianne
    Goodman, Shaun G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (03) : 336 - 343
  • [37] High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
    Hijazi, Ziad
    Wallentin, Lars
    Siegbahn, Agneta
    Andersson, Ulrika
    Alexander, John H.
    Atar, Dan
    Gersh, Bernard J.
    Hanna, Michael
    Harjola, Veli Pekka
    Horowitz, John D.
    Husted, Steen
    Hylek, Elaine M.
    Lopes, Renato D.
    McMurray, John J. V.
    Granger, Christopher B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (01) : 52 - 61
  • [38] Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy
    Guerin, Annie
    Lin, Jay
    Jhaveri, Mehul
    Wu, Eric Q.
    Yu, Andrew P.
    Cloutier, Martin
    Gauthier, Genevieve
    Alpert, Joseph S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) : 564 - 569
  • [39] Withholding Warfarin Therapy for Atrial Fibrillation Patients in the Perioperative Period
    Smoot, Ernest Clyde
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2008, 121 (03) : 155E - 156E
  • [40] Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation
    Gomes, Tara
    Mamdani, Muhammad M.
    Holbrook, Anne M.
    Paterson, J. Michael
    Juurlink, David N.
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (21) : 1687 - 1689
12345